Search Results 41-50 of 16688 for Clenpiq

  1. Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/ ...

  3. Clinical trials - Oncology (Medical)

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

  4. Epilepsy - Doctors and departments - Mayo Clinic

    They include magnetic resonance imaging, subtraction ictal SPECT coregistered to MRI (SISCOM), electroencephalography, ketogenic diet, deep brain stimulation, ...

  5. Gastroenterology and Hepatology - Clinical trials

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  6. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C137 in ...

  7. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  8. Paroxysmal Nocturnal Hemoglobinuria treated with Pegcetacoplan Patient Registry - Mayo Clinic

    About this study. The purpose of this study is to establish a registry to characterize the long-term safety of pegcetacoplan in adult patients with PNH, ...

  9. Untitled

    Page 1.

  10. Pulmonary Medicine Clinical Trials - Medical Professionals

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...